Art-Based Intervention for Hematological Cancer Patients: Randomized Controlled Trial
ClinicalTrials.gov Studies
Summary
A randomized controlled experimental study registered on ClinicalTrials.gov (NCT07551817) examining the effect of art-based intervention on fatigue, anxiety, perception of nurse presence, and quality of life in patients with hematological cancer. The study will enroll 52 patients split into intervention and control groups (26 each) at a training and research hospital Hematology department from May 2025 to October 2026. The intervention group receives art-based sessions three times per week for two weeks, while the control group receives no intervention. Data collection uses Patient Identifier Information Form, Cancer Fatigue Scale, FACT-G, HADS, and Nurse Presence Scale.
“The study will be conducted with 52 patients (26 intervention, 26 control groups) treated in the Hematology department of a training and research hospital between May 2025 and October 2026.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
A new clinical trial registration entry describing a randomized controlled experimental study to evaluate art-based intervention in 52 hematological cancer patients. The intervention group will receive 2 weeks of art-based sessions (3 sessions per week), with the control group receiving no intervention. The study will measure outcomes including fatigue, anxiety, quality of life, and perception of nurse presence using standardized instruments.
This registry entry has no compliance implications for external parties. Healthcare institutions and researchers may note the study parameters as informational only, representing a potential area of supportive care research in hematological malignancies.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
The Effect of Art-Based Intervention on Fatigue, Anxiety, Perception of Nurse Presence, and Quality of Life in Patients With Hematological Cancers
N/A NCT07551817 Kind: NA Apr 27, 2026
Abstract
This study will be conducted in a randomized controlled experimental design to examine The effect of art-based intervention on fatigue, anxiety, perception of nurse presence, and quality of life in patients with hematological cancer. The study will be conducted with 52 patients (26 intervention, 26 control groups) treated in the Hematology department of a training and research hospital between May 2025 and October 2026. Art-based intervention will be applied to the intervention group for 2 week (3 sessions per week), No application will be made to the control group. The data collection tools in the study are the Patient Identifier Information Form, Cancer Fatigue Scale, Functional Assessment of Cancer Therapy-General Scale (FACT-G), Hospital Anxiety and Depression Scale (HADS), and Nurse Presence Scale (PONS).
Conditions: Art-based Intervention, Hematological Cancer, Nurse Presence, Quality of Life, Fatigue, Anxiety
Interventions: art-based intervention
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.